102 However, several teams are advocating for that incorporation of novel markers, such as a complicated karyotype55 or epigenetic subsets, 27,28 into scientific practice. These novel prognostic and/or predictive versions will should be validated in cohorts of individuals treated with targeted brokers. translocations or amplifications on top of the genomic https://gwendolynk208bjv6.jasperwiki.com/user